IOVS Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2005;46:782-790.)
© 2005 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.04-1022

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eckstein, L. A.
Right arrow Articles by O’Brien, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eckstein, L. A.
Right arrow Articles by O’Brien, J. M.

Cyclosporin A Inhibits Calcineurin/Nuclear Factor of Activated T-Cells Signaling and Induces Apoptosis in Retinoblastoma Cells

Lauren A. Eckstein,1 Kurtis R. Van Quill,1 Steven K. Bui,2 Marita S. Uusitalo,3 and Joan M. O’Brien1

1From the Ocular Oncology Unit, Department of Ophthalmology, University of California at San Francisco, San Francisco, California; the 2Department of Ophthalmology, University of California at Irvine, Irvine, California; and the 3Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland.

PURPOSE. Although the clinical efficacy of cyclosporin A (CSA) in retinoblastoma (RB) has been attributed to multidrug resistance reversal activity, the authors hypothesized that CSA is also directly toxic to RB cells through inhibition of calcineurin (CN)/nuclear factor of activated T-cells (NFAT) signaling.

METHODS. Antiproliferative effects of CSA, PSC-833 (a CSA analogue that does not inhibit CN), and FK506 (a CN inhibitor structurally unrelated to CSA) were evaluated in Y79 and Weri-RB1 cells by WST-1 assay. Apoptosis induction by CSA and PSC-833 was measured by detection of caspase 3/7 activity and by flow cytometry, using annexin-V and 7-AAD stains. Expression of CN was assayed in RB cells by immunocytochemistry. Expression of NFAT, a CN-dependent transcription factor family, and FK506 binding protein 12/12.6 (FKBP12/12.6), effectors of CN inhibition by FK506, was assayed in RB cells by Western blot analysis. NFAT activity was assayed in CSA-treated and -untreated Y79 cells transfected with an NFAT-sensitive reporter gene.

RESULTS. CSA induced dose-dependent antiproliferative and proapoptotic effects at clinically achievable levels in Y79 and Weri-RB1 cells. PSC-833 induced antiproliferative effects only at nonphysiologic concentrations with minimal associated apoptosis. FK506 induced minimal antiproliferative effects in RB cell lines, probably due to trace or absent FKBP12/12.6 expression. RB cell lines expressed CN-{alpha}, CN-ß, NFATc1, and NFATc3. CSA treatment also potently inhibited NFAT-mediated reporter gene transcription.

CONCLUSIONS. These results demonstrate functional integrity of the CN/NFAT signaling cascade in RB cells and suggest that CSA is cytotoxic to RB cells through inhibition of this pathway and consequent apoptosis induction.





This article has been cited by other articles:


Home page
Mol Cancer ResHome page
A. H.T. Nguyen, M. Beland, Y. Gaitan, and M. Bouchard
Calcineurin A-Binding Protein, a Novel Modulator of the Calcineurin-Nuclear Factor of Activated T-Cell Signaling Pathway, Is Overexpressed in Wilms' Tumors and Promotes Cell Migration
Mol. Cancer Res., June 1, 2009; 7(6): 821 - 831.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Langworthy, B. Zhou, M. de Caestecker, G. Moeckel, and H. S. Baldwin
NFATc1 Identifies a Population of Proximal Tubule Cell Progenitors
J. Am. Soc. Nephrol., February 1, 2009; 20(2): 311 - 321.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
Z. Li, X. Zhao, S. Bai, Z. Wang, L. Chen, Y. Wei, and C. Huang
Proteomics Identification of Cyclophilin A as a Potential Prognostic Factor and Therapeutic Target in Endometrial Carcinoma
Mol. Cell. Proteomics, October 1, 2008; 7(10): 1810 - 1823.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Dutot, F. Pouzaud, I. Larosche, F. Brignole-Baudouin, J.-M. Warnet, and P. Rat
Fluoroquinolone Eye Drop-Induced Cytotoxicity: Role of Preservative in P2X7 Cell Death Receptor Activation and Apoptosis.
Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 2812 - 2819.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. A. Howard, R. Furumai, M. J. Campa, Z. N. Rabbani, Z. Vujaskovic, X.-F. Wang, and E. F. Patz Jr.
Stable RNA Interference-Mediated Suppression of Cyclophilin A Diminishes Non-Small-Cell Lung Tumor Growth In vivo
Cancer Res., October 1, 2005; 65(19): 8853 - 8860.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
From the Library
Br. J. Ophthalmol., June 1, 2005; 89(6): 788 - 788.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Association for Research in Vision and Ophthalmology